Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 359-368

  Chen, Yinting ^a   Wang, Weiwei ^b   Lian, Guoda ^a   Qian, Chenchen ^a   Wang, Lingyun ^a   Zeng, Linjuan ^a   Liao, Chengde ^c   Liang, Biling ^a   Huang, Bing ^b   Huang, Kaihong ^a   Shuai, Xintao ^b  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

CD44 variant 6; Magnetic resonance imaging; Nonviral vector; Small interfering RNA; Tumor targeting

Indexed keywords

LIPOFECTAMINE; MACROGOL; NANOCARRIER; POLYETHYLENEIMINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CONTRAST MEDIUM; DRUG CARRIER; DRUG DERIVATIVE; MACROGOL DERIVATIVE; NANOPARTICLE; POLY(ETHYLENE GLYCOL) CO POLY(ETHYLENEIMINE); POLY(ETHYLENE GLYCOL)-CO-POLY(ETHYLENEIMINE); CD44V6 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL TRANSPORT; CELL VIABILITY; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; STOMACH CANCER; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOCHEMISTRY; DRUG EFFECT; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METHODOLOGY; NUDE MOUSE; STOMACH TUMOR; TUMOR CELL LINE; AGAR GEL ELECTROPHORESIS; ANTIGEN EXPRESSION; CANCER LOCALIZATION; FLOW CYTOMETRY; MOLECULARLY TARGETED THERAPY;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CONTRAST MEDIA; DRUG CARRIERS; FEMALE; GENETIC VECTORS; HISTOCYTOCHEMISTRY; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; SINGLE-CHAIN ANTIBODIES; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84863055603     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mitelman F. Catalogue of chromosome aberrations in cancer. Cytogenet Cell Genet. 1983;36(1-2):1-515.
2. Desai AM, Pareek M, Nightingale PG, Fielding J W. Improving outcomes in gastric cancer over 20 years. Gastric Cancer. 2004;7(4):196-201.
3. Boyle P. Global burden of cancer. Lancet. 1997;349 Suppl 2: SII23-SII26.
4. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol. 1996;23(3):281-291.
5. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release. 2004;94(1):1-14.
6. Cusack JC Jr, Tanabe KK. Introduction to cancer gene therapy. Surg Oncol Clin N Am. 2002;11(3):497-519.
7. Fischer D, Bieber T, Li Y, Elsässer H P, Kissel T. A novel nonviral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection effciency and cytotoxicity. Pharm Res. 1999;16(8):1273-1279.
8. Ogris M, Brunner S, Schüller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999;6(4):595-605.
9. Fischer D, von Harpe A, Kunath K, Petersen H, Li Y, Kissel T. Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. Bioconjug Chem. 2002;13(5): 1124-1133.
10. Fischer D, Osburg B, Petersen H, Kissel T, Bickel U. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxy-nucleotides in mice. Drug Metab Dispos. 2004;32(9):983-992.
11. Merkel OM, Librizzi D, Pfestroff A, et al. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by fuorescence fuctuation spectroscopy and single photon emission computed tomography (SPECT) imaging. J Control Release. 2009;138(2):148-159.
12. Wu Y, Wang W, Chen Y, et al. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. Int J Nanomedi-cine. 2010;5:129-136.
13. Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006;6(11):2427-2430.
14. Khemtong C, Kessinger C W, Ren J, et al. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superpara-magnetic nanoparticles. Cancer Res. 2009;69(4):1651-1658.
15. Chen G, Chen W, Wu Z, et al. MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosup-pression. Biomaterials. 2009;30(10):1962-1970.
16. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol. 1999;52(4):189-196.
17. Rudzki Z, Jothy S. CD44 and the adhesion of neoplastic cells. Mol Pathol. 1997;50(2):57-71.
18. Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol. 2000;32(1):78-84.
19. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol. 2003;4(1):33-45.
20. Chen Y, Huang K, Li X, Lin X, Zhu Z, Wu Y. Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro. Cancer Immunol Immunother. 2010;59(6):933-942.
21. Sun S, Zeng H, Robinson DB, et al. Monodispersed MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. 2004;126(1):273-279.
22. Hong G, Yuan R, Liang B, Shen J, Yang X, Shuai X. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs. Biomed Microdevices. 2008; 10(5):693-700.
23. Breunig M, Hozsa C, Lungwitz U, et al. Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfde bonds boost intracellular release of the cargo. J Control Release. 2008;130(1): 57-63.
24. Fuchs F, Boutros M. Cellular phenotyping by RNAi. Brief Funct Genomic Proteomic. 2006;5(1):52-56.
25. Cullen LM, Arndt GM. Genome-wide screening for gene function using RNAi in mammalian cells. Immunol Cell Biol. 2005;83(3):217-223.
26. Takeshita F, Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci. 2006;97(8):689-696.
27. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med. 2005;11(1):50-55.
28. Li X, Stuckert P, Bosch I, Marks JD, Marasco WA. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells. Cancer Gene Ther. 2001;8(8):555-565.
29. Song E, Zhu P, Lee SK, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol. 2005; 23(6):709-717.
30. Lungwitz U, Breunig M, Blunk T, Göpferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm. 2005; 60(2):247-266.
31. Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release. 2003;91(1-2):173-181.
32. Leakakos T, Ji C, Lawson G, Peterson C, Goodwin S. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers. Cancer Chemother Pharmacol. 2003;51(6): 445-450.
33. Xiao Y, Forry S P, Gao X, Holbrook RD, Telford WG, Tona A. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake. J Nanobiotechnology. 2010;8:13.